NEBIVOLOL/HYDROCHLOROTHIAZIDE TEVA 5 mg/25 mg, film-coated tablet 30 tablets
Active ingredients: (S,R,R,R)-nebivolol hydrochloride, HYDROCHLOROTHIAZIDE, Nebivolol
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NEBIVOLOL/HYDROCHLOROTHIAZIDE TEVA 5 mg/25 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquettes PVC (ACLAR RX) polytrifluorochloroéthylène PVC-Aluminium de 30 comprimés
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 Apr 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65631198CIP73015594CIP133400930155943Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| HYDROCHLOROTHIAZIDEcomprimé | 25 mg · un comprimé | SA |
| CHLORHYDRATE DE NÉBIVOLOLcomprimé | — | SA |
| NÉBIVOLOLcomprimé | 5 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.